De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Astrana Health Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Astrana Health is de winst gegroeid met een gemiddeld jaarlijks percentage van 22.6%, terwijl de Healthcare industrie de winst jaarlijks groeide met 6.2%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 23% per jaar. Het rendement op eigen vermogen van Astrana Health is 13.9%, en het heeft een nettomarge van 4.3%.
Belangrijke informatie
22.6%
Groei van de winst
17.6%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 8.5% |
| Inkomstengroei | 23.0% |
| Rendement op eigen vermogen | 13.9% |
| Nettomarge | 4.3% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce
Oct 04
Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?
Sep 26Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business
Sep 12Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?
Aug 28Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors
Aug 02Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 09Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)
Apr 15At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Feb 25Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Feb 07Apollo Medical Holdings: Good Company, Not Quite A Hold
Jan 17With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For
Dec 27Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled
Nov 08Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?
Oct 26Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet
Sep 22Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down
Aug 04A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Jul 19We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt
Jun 19Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 05Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?
Apr 20Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Mar 21Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward
Jan 06Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Dec 16Apollo Medical to acquire Valley Oaks Medical Group
Oct 05Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan
Sep 26A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Sep 21The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising
Sep 06With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case
Aug 22Opbrengsten en kosten
Hoe Astrana Health geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 1,592 | 68 | 142 | 0 |
| 31 Mar 24 | 1,454 | 62 | 130 | 0 |
| 31 Dec 23 | 1,387 | 61 | 113 | 0 |
| 30 Sep 23 | 1,328 | 45 | 99 | 0 |
| 30 Jun 23 | 1,297 | 46 | 91 | 0 |
| 31 Mar 23 | 1,218 | 45 | 87 | 0 |
| 31 Dec 22 | 1,144 | 45 | 78 | 0 |
| 30 Sep 22 | 1,045 | 58 | 67 | 0 |
| 30 Jun 22 | 955 | 69 | 68 | 0 |
| 31 Mar 22 | 861 | 70 | 62 | 0 |
| 31 Dec 21 | 774 | 69 | 62 | 0 |
| 30 Sep 21 | 756 | 70 | 55 | 0 |
| 30 Jun 21 | 709 | 53 | 49 | 0 |
| 31 Mar 21 | 698 | 47 | 47 | 0 |
| 31 Dec 20 | 687 | 38 | 49 | 0 |
| 30 Sep 20 | 689 | 35 | 51 | 0 |
| 30 Jun 20 | 665 | 22 | 43 | 0 |
| 31 Mar 20 | 630 | 18 | 41 | 0 |
| 31 Dec 19 | 561 | 14 | 40 | 0 |
| 30 Sep 19 | 488 | 4 | 44 | 0 |
| 30 Jun 19 | 499 | 10 | 45 | 0 |
| 31 Mar 19 | 492 | 9 | 46 | 0 |
| 31 Dec 18 | 520 | 11 | 47 | 0 |
| 30 Sep 18 | 506 | 28 | 42 | 0 |
| 30 Jun 18 | 436 | 24 | 38 | 0 |
| 31 Mar 18 | 395 | 24 | 33 | 0 |
| 31 Dec 17 | 356 | 26 | 26 | 0 |
| 30 Sep 17 | 336 | 13 | 22 | 0 |
| 30 Jun 17 | 323 | 11 | 23 | 0 |
| 31 Mar 17 | 317 | 12 | 22 | 0 |
| 31 Dec 16 | 306 | 11 | 21 | 0 |
| 31 Dec 15 | 313 | 13 | 27 | 0 |
| 31 Dec 14 | 134 | -1 | 36 | 0 |
Kwaliteitswinsten: ASTH heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (4.3%) ASTH } zijn hoger dan vorig jaar (3.5%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van ASTH is de afgelopen 5 jaar aanzienlijk gegroeid met 22.6% per jaar.
Versnelling van de groei: De winstgroei van ASTH over het afgelopen jaar ( 49.5% ) overtreft het 5-jarig gemiddelde ( 22.6% per jaar).
Winst versus industrie: De winstgroei ASTH over het afgelopen jaar ( 49.5% ) overtrof de Healthcare -sector 8%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 13.9% ) van ASTH wordt als laag beschouwd.